Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2010. The report serves as a notification to the U.S. Securities and Exchange Commission regarding a change in major shareholding interests, specifically a notification received from Legal & General Group plc on August 2, 2010, in accordance with Disclosure and Transparency Rules (DTR 5.8.12).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of share ownership changes rather than a financial performance report.
Material Changes
- Shareholder Interest Reduction: Legal & General Group plc (L&G) reduced its voting rights in GlaxoSmithKline plc Ordinary shares from 4% to 3%.
- Transaction Date: The transaction triggering this change occurred on July 30, 2010.
- Current Holdings: Following the transaction, L&G holds 207,179,146 shares, representing 3.98% of the total voting rights (based on a total of 5,192,618,078 voting rights).
- Instrument Type: The change resulted from an acquisition or disposal of voting rights attached to ordinary shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly limited to the disclosure of the change in major shareholding.
Investor Verification Checklist
- Verify the exact number of shares held by Legal & General Group plc (207,179,146) and the resulting percentage (3.98%).
- Confirm the date of the transaction (July 30, 2010) versus the notification date (August 2, 2010).
- Review the chain of controlled undertakings to understand the specific entities within the L&G group holding the shares (e.g., Legal & General Assurance (Pensions Management) Limited).
- Check subsequent filings to determine if the 3% threshold was maintained or if further disposals occurred.